US · Healthcare

Defence Therapeutics Inc (DTCFF)

Biotechnology

Defence Therapeutics Inc (DTCFF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DTCFF

P/E ratio

18.00

Defence Therapeutics Inc (DTCFF) — FAQ

What is DTCFF's P/E ratio?

The price-to-earnings (P/E) ratio for Defence Therapeutics Inc (DTCFF) is 18.00 (data as of 2026-03-24).

Does Defence Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Defence Therapeutics Inc (DTCFF). Check the MyAverix Finance app for the latest dividend data.

What sector is Defence Therapeutics Inc in?

Defence Therapeutics Inc (DTCFF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DTCFF listed on?

DTCFF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)